This study investigates clinical and demographic characteristics, C9orf72 expansion status, APOE genotypes, and ATXN1/ATXN2 repeat lengths in ALS/FTD patients and controls, with a comparative analysis between carriers and non-carriers of the C9orf72 repeat expansion. This evidence concerns the gene ATXN2 and frontotemporal dementia.